Skip to content
DraconiticResearch
Search Sources API
194,216 studies31 sourcesUpdated 28 min ago
PreprintAll rights reservedbioRxiv

Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction

  1. 1AcSIR, CSIR-Central Drug Research Institute

Related

  1. Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein
    Nouh Mounadi, Hassan Nour, M’hammed El Kouali +2
    PLOS OnePeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPLOS
  2. High-throughput screening to identify inhibitors of the MTB CARD•RNA polymerase protein-protein interaction
    Glory M. Velazquez, Jonathan Z. Sexton, Scott G. Franzblau +3
    Frontiers in tuberculosisPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Sigma‐1 Receptor‐Targeting Compounds Show Antiviral Activity Across Multiple Coronavirus Models
    Cuiling Zhang, Xingpeng Dong, Jiaying Liu +7
    Journal of medical virologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Antiviral activity of HSP90 inhibitors against Mumps virus and related paramyxoviruses
    Fumihiro Kato, Chaewon Bae, Aika Wakata +16
    Scientific ReportsPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossref
  5. Seesaw configuration of the ODC-OAZ1-AZIN1 axis governs sensitivity to polyamine-targeting inhibitors of breast cancer cells
    Y. Gao, J. Li, Y. Jiao +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
BibTeX
@misc{mishra2026identification,
  title = {{Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction}},
  author = {P. Mishra and S. Mishra and G. Srivastava and K. Archana and M. I. Siddiqi and S. Haldar and R. K. Tripathi},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.23.753689},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.23.753689v1},
}
RIS
TY  - UNPB
TI  - Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction
AU  - P. Mishra
AU  - S. Mishra
AU  - G. Srivastava
AU  - K. Archana
AU  - M. I. Siddiqi
AU  - S. Haldar
AU  - R. K. Tripathi
PY  - 2026
DA  - 2026/09/23
PB  - bioRxiv
DO  - 10.64898/2026.09.23.753689
UR  - https://www.biorxiv.org/content/10.64898/2026.09.23.753689v1
ER  -